Good morning, everyone, and nice to see you again. We have returned from an extended weekend respite that was due to a holiday on this side of the pond. But now, of course, we are gearing up for the usual routine of meetings, deadlines, and the like. No doubt, you can relate. So please join us for a refreshing cup of stimulation as we dig in for a busy day. Remember, no prescription is required, which also means you do not have to puzzle over rebates or copays. Meanwhile, here are some tidbits. Hope your day is successful and, as always, do keep in touch …

A former Biogen (BIIB) employee filed a lawsuit accusing the drug maker of failing to accommodate his Parkinson’s disease, even as the company was developing a drug for the condition, the Boston Business Journal writes. Aldrin Carao, who was hired in 2012 and had been diagnosed with the disease seven years earlier, claims that Biogen discriminated against him and backtracked on accommodations it had made for his disease before abruptly firing him in February 2016. His disease worsened over his final two years of employment, impacting his speech and ability to type.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy